moxifloxacin has been researched along with Bronchial Pneumonia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noreddin, AM; Salem, AH | 1 |
| Alteraz, H; Blau, H; Fabian, I; Horev-Azaria, L; Kariv, N; Kletter, Y; Shalit, I; Shechtman, I | 1 |
| Albanese, J; Arvis, P; Bruguerolle, B; Lacarelle, B; Martin, C; Sampol, E; Simon, N; Urien, S | 1 |
1 trial(s) available for moxifloxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Area Under Curve; Aza Compounds; Bronchi; Bronchoalveolar Lavage Fluid; Bronchopneumonia; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Prospective Studies; Quinolines; Tissue Distribution | 2003 |
3 other study(ies) available for moxifloxacin and Bronchial Pneumonia
| Article | Year |
|---|---|
Moxifloxacin in lower respiratory tract infections: in silico simulation of different bacterial resistance and drug exposure scenarios.
Topics: Area Under Curve; Bronchopneumonia; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2014 |
Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Body Weight; Bronchopneumonia; Candidiasis; Ceftazidime; Cephalosporins; Cyclophosphamide; Cytokines; Fluoroquinolones; Lung; Male; Mice; Mice, Inbred BALB C; Moxifloxacin; Neutropenia; Protein Synthesis Inhibitors; Quinolines; Survival | 2002 |
[Playing it safe in bronchopulmonary infections].
Topics: Anti-Infective Agents; Aza Compounds; Bronchopneumonia; Community-Acquired Infections; Drug Resistance, Multiple; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic | 2003 |